Correction: Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy 🔗 Access full article via Journal for ImmunoTherapy of CancerShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
